• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.32% Nasdaq Down 0.01%

    Agios Pharmaceuticals, Inc. (AGIO)

    -NasdaqGS
    110.18 Up 1.27(1.17%) Jul 31, 4:00PM EDT
    |After Hours : 110.18 0.00 (0.00%) Jul 31, 4:22PM EDT
    Add to Portfolio
    Prev Close:108.91
    Open:109.57
    Bid:99.05 x 100
    Ask:125.00 x 200
    1y Target Est:124.00
    Beta:1.979
    Next Earnings Date: 6-Aug-15AGIO Earnings announcement
    Day's Range:108.06 - 112.56
    52wk Range:36.44 - 138.85
    Volume:249,453
    Avg Vol (3m):603,098
    Market Cap:4.11B
    P/E (ttm):N/A
    EPS (ttm):-1.32
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for AGIO

    Comparison

    Symbol% ChgMkt Cap
    AGIOUp 1.17%4.11B
    ALXNDown 0.93%44.25B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):44.57
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-2.06
    Quarterly EPS Est (Jun-15) :-0.46
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Agios Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics in the field of cancer metabolism and rare genetic disorders of metabolism in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback